Dissecting the Natural Patterns of Progression and Senescence in Pediatric Low-Grade Glioma: From Cellular Mechanisms to Clinical Implications.

Autor: Gorodezki D; Department of Hematology and Oncology, University Children's Hospital Tübingen, 72076 Tübingen, Germany., Schuhmann MU; Section of Pediatric Neurosurgery, Department of Neurosurgery, University Hospital Tübingen, 72076 Tübingen, Germany., Ebinger M; Department of Hematology and Oncology, University Children's Hospital Tübingen, 72076 Tübingen, Germany., Schittenhelm J; Department of Neuropathology, Institute of Pathology, University Hospital Tübingen, 72076 Tübingen, Germany.
Jazyk: angličtina
Zdroj: Cells [Cells] 2024 Jul 19; Vol. 13 (14). Date of Electronic Publication: 2024 Jul 19.
DOI: 10.3390/cells13141215
Abstrakt: Pediatric low-grade gliomas (PLGGs) comprise a heterogeneous set of low-grade glial and glioneuronal tumors, collectively representing the most frequent CNS tumors of childhood and adolescence. Despite excellent overall survival rates, the chronic nature of the disease bears a high risk of long-term disease- and therapy-related morbidity in affected patients. Recent in-depth molecular profiling and studies of the genetic landscape of PLGGs led to the discovery of the paramount role of frequent upregulation of RAS/MAPK and mTOR signaling in tumorigenesis and progression of these tumors. Beyond, the subsequent unveiling of RAS/MAPK-driven oncogene-induced senescence in these tumors may shape the understanding of the molecular mechanisms determining the versatile progression patterns of PLGGs, potentially providing a promising target for novel therapies. Recent in vitro and in vivo studies moreover indicate a strong dependence of PLGG formation and growth on the tumor microenvironment. In this work, we provide an overview of the current understanding of the multilayered cellular mechanisms and clinical factors determining the natural progression patterns and the characteristic biological behavior of these tumors, aiming to provide a foundation for advanced stratification for the management of these tumors within a multimodal treatment approach.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje